Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

United States Specialty Pharmaceuticals Market & Forecast by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, AMD, HGH, Others), Companies

Published by Renub Research Product code 973149
Published Content info 155 Pages
Delivery time: 1-2 business days
Price
Back to Top
United States Specialty Pharmaceuticals Market & Forecast by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, AMD, HGH, Others), Companies
Published: November 1, 2020 Content info: 155 Pages
Description

In the United States, the Pharmaceutical market can be categories into two types of drugs Traditional as well as Specialty drugs. In recent times, Specialty drugs have gained a substantial foothold in the US market, and as estimated, it tends to gain more momentum in the upcoming years. For this, the credit goes to the companies initiatives towards Research and Developments (R&D's) of these drugs. As per Renub Research Analysis, it is expected that United States Specialty Pharmaceutical Market will be US$ 387 Billion by 2026.

During the years, Specialty pharmaceutical has changed much due to speciality drugs being in the final stages of development in the United States. Speciality drugs are for rare and chronic diseases, and the drugs fall under this category are much expensive compared to traditional medications. Research has shown that a large portion of the US population was ageing and more people are prone towards chronic and rare diseases like cancer, Autoimmune, Multiple sclerosis.

In the year 2018, the FDA has approved 21 new molecular entities. Out of these products, 12 are regarded as speciality pharmaceutical based on variables such as indication and designed use population, administrative and tracking considerations, price and restricted delivery procedures. Dating back five years, spending on speciality drugs has almost doubled in the United States.

An ageing population, rise in the net per capita medicine spending on speciality drugs, improving life expectancy rate, the prevalence of chronic diseases are likely to boost the United States Specialty pharmaceuticals market at a staggering rate in upcoming years.

Renub Research report titled "United States Specialty Pharmaceuticals Market, by Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Hematology, Age-related macular degeneration (AMD), Human Growth Hormones (HGH) Others), Company ( CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Analysis" provides a complete analysis of United States Specialty Pharmaceutical Market.

All the 9 Diseases have been studied from two points

  • Market
  • Drugs Pipeline

Application - The Report Covers the Market, Drugs Pipelines of 9 diseases

  • 1. Oncology
  • 2. Autoimmune
  • 3. Immunology
  • 4. HIV
  • 5. Multiple Sclerosis
  • 6. Hematology
  • 7. Age-related macular degeneration (AMD)
  • 8. Human Growth Hormones (HGH)
  • 9. Others

All the Key players have been covered from 3 Viewpoints

  • Overview
  • Recent Developments
  • Revenue Analysis

Company Analysis

  • CVS Health
  • Endo International
  • UnitedHealth Group Incorporated
  • Recordati Pharmaceuticals
Table of Contents

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges
  • 4.3 Trend and Opportunities

5. Market Analysis - United States Specialty Pharmaceuticals

  • 5.1 Market
  • 5.2 Specialty Drug Pipeline

6. Share Analysis

  • 6.1 Applications
  • 6.2 Segments
    • 6.2.1 Traditional
    • 6.2.2 Specialty

7. By Applications

  • 7.1 Oncology
    • 7.1.1 Market
    • 7.1.2 Pipelines
  • 7.2 Autoimmune
    • 7.2.1 Market
    • 7.2.2 Pipelines
  • 7.3 HIV
    • 7.3.1 Market
    • 7.3.2 Pipelines
  • 7.4 Immunology
    • 7.4.1 Market
    • 7.4.2 Pipelines
  • 7.5 Multiple Sclerosis (MS)
    • 7.5.1 Market
    • 7.5.2 Pipelines
  • 7.6 Hematology
    • 7.6.1 Market
  • 7.7 Age-related macular degeneration (AMD)
    • 7.7.1 Market
    • 7.7.2 Pipelines
  • 7.8 Human Growth Hormones (HGH)
    • 7.8.1 Market
    • 7.8.2 Pipelines
  • 7.9 Others

8. Key Players Analysis

  • 8.1 CVS Health
    • 8.1.1 Overview
    • 8.1.2 Recent Developments
    • 8.1.3 Revenues
  • 8.2 Endo International
    • 8.2.1 Overview
    • 8.2.2 Recent Developments
    • 8.2.3 Revenues
  • 8.3 UnitedHealth Group Incorporated
    • 8.3.1 Overview
    • 8.3.2 Recent Developments
    • 8.3.3 Revenues
  • 8.4 Recordati Pharmaceuticals
    • 8.4.1 Overview
    • 8.4.2 Recent Developments
    • 8.4.3 Revenues

List of Figures

  • Figure-01: Excess Revenues Earned Through Premium Pricing Of Products In The US As A Percentage Of The Company's Global Research And Development Expenditures, 2015
  • Figure-02: United States - Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
  • Figure-03: United States - Forecast For Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
  • Figure-04: United States - Market Share By Traditional vs Specialty, (Percent), 2015 - 2020
  • Figure-05: United States - Forecast for Market Share By Traditional vs Specialty, (Percent), 2021 - 2026
  • Figure-06: By Application - Oncology Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
  • Figure-07: By Application - Forecast for Oncology Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
  • Figure-08: By Application - Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
  • Figure-09: By Application - Forecast for Autoimmune Specialty Pharmaceuticals Market, (Billion US$), 2021 - 2026
  • Figure-10: By Application - HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
  • Figure-11: By Application - Forecast for HIV Specialty Pharmaceuticals Market, (Billion US$), 2015 - 2020
  • Figure-12: By Application - Immunology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
  • Figure-13: By Application - Forecast for Immunology Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-14: By Application - Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
  • Figure-15: By Application - Forecast for Multiple Sclerosis Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-16: By Application - Hematology Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
  • Figure-17: By Application - Forecast for Hematology Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-18: By Application - Age Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
  • Figure-19: By Application - Forecast for Age Related Macular Degeneration Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-20: By Application - Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2015 - 2020
  • Figure-21: By Application - Forecast for Human Growth Hormones Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-22: By Application - Others Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-23: By Application - Forecast for Others Specialty Pharmaceutical Market (Billion US$), 2021 - 2026
  • Figure-24: Forecast For CVS Health Revenue Market (Million US$), 2021 - 2026
  • Figure-25: Global - Endo International Specialty Products Revenue (Million US$), 2015 - 2020
  • Figure-26: Global - Forecast For Endo International Specialty ProductsRevenue (Million US$), 2021 - 2026
  • Figure-27: Global - UnitedHealth Group Incorporated Revenue (Million US$), 2015 - 2020
  • Figure-28: Global - Forecast For United Health Group Incorporated Revenue (Million US$), 2021 - 2026
  • Figure-29: Global - Recordati Pharmaceuticals Ltd Revenue (Million US$), 2015 - 2020
  • Figure-30: Global - Forecast For Recordati Pharmaceuticals Ltd Revenue (Million US$), 2021 - 2026

List of Tables

  • Table-01: Specialty New Product Approvals in the Past Twelve Months
  • Table-02: United States - Market Share By Applications, (Percent), 2015 - 2020
  • Table-03: United States - Forecast for Market Share By Applications, (Percent), 2021 - 2026
  • Table-04: United States - Oncology Specialty Drug/R&D Pipeline
  • Table-05: Drugs Pipelines - 2020
  • Table-06: Specialty Drugs Pipeline - 2020
Back to Top